GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bonus BioGroup Ltd (XTAE:BONS) » Definitions » Marketable Securities

Bonus BioGroup (XTAE:BONS) Marketable Securities : ₪0.00 Mil (As of Dec. 2024)


View and export this data going back to 1993. Start your Free Trial

What is Bonus BioGroup Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Bonus BioGroup's Marketable Securities for the quarter that ended in Dec. 2024 was ₪0.00 Mil.


Bonus BioGroup Marketable Securities Historical Data

The historical data trend for Bonus BioGroup's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bonus BioGroup Marketable Securities Chart

Bonus BioGroup Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Bonus BioGroup Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Bonus BioGroup Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Bonus BioGroup  (XTAE:BONS) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".


Bonus BioGroup Marketable Securities Related Terms

Thank you for viewing the detailed overview of Bonus BioGroup's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Bonus BioGroup Business Description

Traded in Other Exchanges
Address
Matam Advanced, Technology Park, P.O.B 15143, Haifa, ISR, 31905
Bonus BioGroup Ltd is an clinical-stage biotechnology company developing next-generation therapies for a variety of indications in the regenerative medicine field. Its products products, BonoFill and MesenCure.

Bonus BioGroup Headlines

No Headlines